Malignant plasma cells are sensitive to LAK cell lysis: pre‐clinical and clinical studies of interleukin 2 in the treatment of multiple myeloma

David J. Gottlieb, H. Grant Prentice, Atul B. Mehta, Andrew R. Galazka, Helen E. Heslop, A. Victor Hoffbrand, Malcolm K. Brenner

Research output: Contribution to journalArticle

28 Scopus citations

Fingerprint Dive into the research topics of 'Malignant plasma cells are sensitive to LAK cell lysis: pre‐clinical and clinical studies of interleukin 2 in the treatment of multiple myeloma'. Together they form a unique fingerprint.

Medicine & Life Sciences